Compass Pathways company information, Employees & Contact Information

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025 Business Wire

Privacy notice Compass Pathways

Compass Pathways Appoints Justin Gover to Board of Directors Yahoo Finance

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights Investing News Network

Compass Pathways to Participate in Four Investor Conferences in September Business Wire

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA Yahoo Finance

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET Investing News Network

Compass Pathways Secures $150M Funding for Breakthrough Depression Treatment Trials Stock Titan

COMP360 psilocybin treatment in TRD Compass Pathways

Compass Pathways to Participate in Four Investor Conferences in September Investing News Network

Our Values & Mental Health Innovations Compass Pathways

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression Investing News Network

About psilocybin therapy Compass Pathways

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder Business Wire

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression Investing News Network

Therapist training Compass Pathways

Treatment-resistant depression (TRD) Compass Pathways

Contact us Compass Pathways

Gina | Our stories Compass Pathways

COMP360 psilocybin treatment in TRD with antidepressants Compass Pathways

Welcome to our Annual Review 2023 Compass Pathways

Kabir Nath Compass Pathways

Compassionate use policy Compass Pathways

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates Business Wire

Coordinating clinical trials: a day in the life Compass Pathways

Centres of Excellence Compass Pathways

Investigator-Initiated Studies, Research & Clinical Trials Compass Pathways

Lucinda: on values and outcomes research and a love of the outdoors Compass Pathways

Gary: on a book about a giant spaceship and music for mindfulness Compass Pathways

Leading a mental health charity Compass Pathways

Ekaterina Malievskaia MD Compass Pathways

Post-traumatic stress disorder (PTSD) Compass Pathways

Psychological therapist Nadav Liam Modlin talks about PTSD Compass Pathways

Compass Pathways plc Terms of Service Compass Pathways

COMPASS Pathways announces positive topline results from GlobeNewswire

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors Yahoo Finance

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression Psychedelic Alpha

COMPASS Pathways’ key patents upheld by the US Patent and Trademark Office Psychedelic Alpha

COMPASS Pathways granted fifth US patent for crystalline psilocybin Psychedelic Alpha

COMPASS Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital GlobeNewswire

COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study Psychedelic Alpha

COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression PR Newswire

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists GlobeNewswire

COMPASS Pathways and King's College London Announce Results From Psilocybin Study In Healthy Volunteers PR Newswire

COMPASS Pathways granted two US patents GlobeNewswire

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO GlobeNewswire